Mannitol Injection USP 20 %

Mannitol Injection USP 20% is an intravenous solution used for various medical purposes, including fluid replacement and reducing intracranial pressure. This sterile solution is manufactured by ICU Medical Canada Inc.

Mannitol Injection USP 20% is commonly used to promote diuresis, which helps the kidneys remove excess fluid and waste from the body. It is also used to reduce intracranial pressure and promote urine output in certain medical conditions. This solution is administered intravenously and is often used in hospital settings.

Mannitol Injection USP 20% works by drawing water out of the tissues and into the bloodstream, which can help reduce swelling and increase urine output. This process can help alleviate symptoms associated with fluid retention and high intracranial pressure. The effects typically occur within a short period after administration.

Mannitol Injection USP 20% should be used with caution in patients with certain medical conditions, such as heart failure or kidney disease. It is important to follow the instructions provided by a healthcare professional and to monitor the patient's response to the treatment. Always ensure the solution is stored properly and administered correctly.

Mannitol Injection USP 20% may interact with certain medications, including diuretics and other drugs that affect kidney function. It is important to inform a healthcare professional about all medications being taken before starting treatment with Mannitol Injection USP 20%. Additionally, alcohol and other substances may affect the efficacy and safety of the solution.